Cargando…
Analysis of the phosphoproteome of CK2α((–/–))/Δα′ C2C12 myoblasts compared to the wild-type cells
CK2 is a Ser/Thr protein kinase composed of two catalytic (α/α′) subunits and a non-catalytic β-subunit dimer, whose activity is often abnormally high in cancer cells. The concept that CK2 may be dispensable for cell survival has been challenged by the finding that viable CK2α/α′ knock-out myoblast...
Autores principales: | Borgo, Christian, Cesaro, Luca, Hirota, Tsuyoshi, Kuwata, Keiko, D'Amore, Claudio, Ruppert, Thomas, Blatnik, Renata, Salvi, Mauro, Pinna, Lorenzo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943641/ https://www.ncbi.nlm.nih.gov/pubmed/36809799 http://dx.doi.org/10.1098/rsob.220220 |
Ejemplares similares
-
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance
por: D’Amore, Claudio, et al.
Publicado: (2020) -
Protein kinase CK2: a potential therapeutic target for diverse human diseases
por: Borgo, Christian, et al.
Publicado: (2021) -
Exploring the CK2 Paradox: Restless, Dangerous, Dispensable
por: Franchin, Cinzia, et al.
Publicado: (2017) -
Protein Kinase CK2 Subunits Differentially Perturb the Adhesion and Migration of GN11 Cells: A Model of Immature Migrating Neurons
por: Lettieri, Antonella, et al.
Publicado: (2019) -
Targeting CK2 in cancer: a valuable strategy or a waste of time?
por: Salvi, Mauro, et al.
Publicado: (2021)